Articles related to ATRIAL FIBRILLATION (AFIB)

This study underscores the critical need for precise diagnostic criteria in treating unexplained strokes and the potential reevaluation of anticoagulant use in patients with atrial cardiopathy, opening new avenues for research and patient care.

In the landscape of cardiac monitoring, consumer-grade smart devices have shown a remarkable ability to detect atrial fibrillation with high sensitivity and specificity, challenging the traditional reliance on medical-grade monitoring tools.

The study’s findings call for risk stratification and follow-up in patients with transient new-onset AF during hospitalization.

This study offers valuable insights into the comparative efficacy and safety of apixaban and rivaroxaban in obese patients with NVAF, highlighting the need for a patient-centered approach in anticoagulant selection.

Marlex Pharmaceuticals has initiated a critical recall of specific lots of Digoxin Tablets due to a labeling error. Physicians are urged to exercise extreme caution and verify their inventory to prevent adverse patient outcomes.

The SAGE-AF study provides valuable insights into the cost-reducing behaviors among older adults with atrial fibrillation, highlighting the need for targeted interventions, especially for those with cognitive impairments. Explore the study to understand how these behaviors are shaping medication management in this vulnerable population.